Your browser doesn't support javascript.
loading
Factors Associated with Loss to Follow-up among Cervical Cancer Patients in Rwanda.
Habinshuti, Placide; Hagenimana, Marc; Nguyen, Cam; Park, Paul H; Mpunga, Tharcisse; Shulman, Lawrence N; Fehr, Alexandra; Rukundo, Gilbert; Bigirimana, Jean Bosco; Teeple, Stephanie; Kigonya, Catherine; Ndayisaba, Gilles Francois; Uwinkindi, Francois; Randall, Thomas; Miller, Ann C.
Affiliation
  • Habinshuti P; Partners in Health/Inshuti Mu Buzima, RW.
  • Hagenimana M; Rwanda Biomedical Center/Non-Communicable Diseases division, RW.
  • Nguyen C; Partners in Health/Inshuti Mu Buzima, RW.
  • Park PH; Partners in Health/Boston, US.
  • Mpunga T; Harvard Medical School, US.
  • Shulman LN; Brigham and Women's Hospital, US.
  • Fehr A; Ministry of Health/Butaro Hospital, RW.
  • Rukundo G; University of Pennsylvania, US.
  • Bigirimana JB; Partners in Health/Inshuti Mu Buzima, RW.
  • Teeple S; Athena Institute of Vrije Universiteit, NL.
  • Kigonya C; Partners in Health/Inshuti Mu Buzima, RW.
  • Ndayisaba GF; Partners in Health/Inshuti Mu Buzima, RW.
  • Uwinkindi F; University of Pennsylvania, US.
  • Randall T; Partners in Health/Inshuti Mu Buzima, RW.
  • Miller AC; Rwanda Biomedical Center/Non-Communicable Diseases division, RW.
Ann Glob Health ; 86(1): 117, 2020 09 14.
Article in En | MEDLINE | ID: mdl-32983913
ABSTRACT

Background:

Cervical cancer is among the most common cancers affecting women globally. Where treatment is available in low- and middle-income countries, many women become lost to follow-up (LTFU) at various points of care.

Objective:

This study assessed predictors of LTFU among cervical cancer patients in rural Rwanda.

Methods:

We conducted a retrospective study of cervical cancer patients enrolled at Butaro Cancer Center of Excellence (BCCOE) between 2012 and 2017 who were either alive and in care or LTFU at 12 months after enrollment. Patients are considered early LTFU if they did not return to clinic after the first visit and late LTFU if they did not return to clinic after the second visit. We conducted two multivariable logistic regressions to determine predictors of early and late LTFU.

Findings:

Of 652 patients in the program, 312 women met inclusion criteria, of whom 47 (15.1%) were early LTFU, 78 (25.0%) were late LTFU and 187 (59.9%) were alive and in care. In adjusted analyses, patients with no documented disease stage at presentation were more likely to be early LTFU vs. patients with stage 1 and 2 when controlling for other factors (aOR 14.93, 95% CI 6.12-36.43). Patients who travel long distances (aOR 2.25, 95% CI 1.11, 4.53), with palliative care as type of treatment received (aOR 6.65, CI 2.28, 19.40) and patients with missing treatment (aOR 7.99, CI 3.56, 17.97) were more likely to be late LTFU when controlling for other factors. Patients with ECOG status of 2 and higher were less likely to be late LTFU (aOR 0.26, 95% CI 0.08, 0.85).

Conclusion:

Different factors were associated with early and later LTFU. Enhanced patient education, mechanisms to facilitate diagnosis at early stages of disease, and strategies that improve patient tracking and follow-up may reduce LTFU and improve patient retention.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Uterine Cervical Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Africa Language: En Journal: Ann Glob Health Year: 2020 Type: Article Affiliation country: Rwanda

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Uterine Cervical Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Africa Language: En Journal: Ann Glob Health Year: 2020 Type: Article Affiliation country: Rwanda